1h Free Analyst Time
Teijin Ltd (3401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Teijin Ltd (Teijin) is a technology-driven holding company that offers solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It manufactures and sells aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products and pharmaceutical products. The company offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, and other diseases. It also offers homecare services such as home oxygen therapy devices, sonic accelerated fracture healing systems and sleep-disordered breathing-related devices, among others. Teijin operates facilities in Europe, America, Asia and Japan. The company sells its products in Asia, the Americas and Europe. Teijin is headquartered in Tokyo, Japan.Teijin Ltd Key Recent Developments
May 11, 2023: Teijin Announces Consolidated Financial Statements Summary (For the year ended March 31, 2023)Feb 21, 2023: Teijin and Axcelead sign deal for drug discovery research JV
Feb 08, 2023: Teijin Announces Consolidated Financial Statements Summary For the nine months ended December 31, 2022
Sep 27, 2022: Teijin, J-TEC, Mitsui Fudosan and NCC to Establish Regenerative Medicine Platform
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- Sumitomo Chemical Co Ltd
- Takeda Pharmaceutical Co Ltd
- Dow Chemical Co
- Celanese Corp
- Mitsubishi Chemical Corp
- Kaneka Corp
- Nippon Chemical Industrial Co Ltd